MEADE HARRY 4
4 · GTC BIOTHERAPEUTICS INC · Filed Jul 2, 2009
Insider Transaction Report
Form 4
MEADE HARRY
SVP, Transgenic Research
Transactions
- Tax Payment
Common Stock
2009-06-30$2.66/sh−1,165$3,099→ 15,854 total
Holdings
- 5,302(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]The shares reported were withheld to pay a tax liability in connection with the vesting of restricted stock units, which units were previously reported on a prior Form 4 filed by Dr. Meade.
- [F2]On May 26, 2009 the issuer effected a one-for-ten reverse stock split of its outstanding common stock, resulting in the reporting person owning 153,193 fewer shares of common stock.
- [F3]On May 26, 2009 the issuer effected a one-for-ten reverse stock split of its outstanding common stock, resulting in the reporting person owning 47,726 fewer shares of common stock in his 401(k).